|
Jul 1
|
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Jun 30
|
Protara Therapeutics Announces Addition to the Russell 3000® Index
|
|
May 22
|
Richard Levy Spends US$64k On Protara Therapeutics Stock
|
|
Apr 15
|
Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
|
|
Apr 10
|
Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
|
|
Feb 26
|
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
|